| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446279 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
In the Netherlands, a rising incidence is seen for oesophageal adenocarcinoma, but not for gastric cardia adenocarcinoma. This finding most likely reflects true changes in disease burden, rather than being the result of changes in diagnosis or classification. The increased survival for oesophageal carcinoma can be attributed to centralisation of surgery, and an increased use of multimodality therapy, factors hardly acknowledged for gastric cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Johan L. Dikken, Valery E. Lemmens, Michel W.J.M. Wouters, Bas P. Wijnhoven, Peter D. Siersema, Grard A. Nieuwenhuijzen, Johanna W. van Sandick, Annemieke Cats, Marcel Verheij, Jan Willem Coebergh, Cornelis J.H. van de Velde,